170 related articles for article (PubMed ID: 24363883)
1. Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.
Tandra P; Krishnamurthy J; Bhatt VR; Newman K; Armitage JO; Akhtari M
Mediterr J Hematol Infect Dis; 2013 Nov; 5(1):e2013068. PubMed ID: 24363883
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
3. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
5. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune cytopenias in chronic lymphocytic leukemia.
D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune complications of chronic lymphocytic leukemia.
Hamblin TJ
Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
[TBL] [Abstract][Full Text] [Related]
11. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune cytopenias in chronic lymphocytic leukemia.
Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
[TBL] [Abstract][Full Text] [Related]
14. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects.
Fattizzo B; Barcellini W
Front Oncol; 2019; 9():1435. PubMed ID: 31998632
[TBL] [Abstract][Full Text] [Related]
16. Can Treatment with Venetoclax for Chronic Lymphocytic Leukemia (CLL) Result In Autoimmune Hemolytic Anemia?
Abdel-Samad N; Sughayar R
Am J Case Rep; 2021 Mar; 22():e928514. PubMed ID: 33750754
[TBL] [Abstract][Full Text] [Related]
17. The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia.
Noto A; Cassin R; Mattiello V; Reda G
J Clin Med; 2021 May; 10(10):. PubMed ID: 34065833
[TBL] [Abstract][Full Text] [Related]
18. Disease-specific complications of chronic lymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program; 2008; ():450-6. PubMed ID: 19074125
[TBL] [Abstract][Full Text] [Related]
19. The pathologic significance of the immunoglobulins expressed by chronic lymphocytic leukemia B-cells in the development of autoimmune hemolytic anemia.
Efremov DG; Ivanovski M; Burrone OR
Leuk Lymphoma; 1998 Jan; 28(3-4):285-93. PubMed ID: 9517500
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review.
Autore F; Pasquale R; Innocenti I; Fresa A; Sora' F; Laurenti L
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]